Mounjaro and a Runny Nose: Should You Be Concerned?

What the licensed side-effect data actually says

Tirzepatide's clinical trial programme (running across the SURMOUNT studies involving thousands of adults) generated a detailed picture of how the medicine affects the body. The side effects reported most often were nausea, vomiting, diarrhoea, constipation and indigestion, all of which make sense given the medicine slows gastric emptying and alters gut-hormone signalling. Rhinorrhoea (the medical term for a runny nose) was not among the commonly reported adverse reactions in those trials.

That does not mean it can't happen. Rare and very rare side effects exist for almost every medicine, and individual variation is real. The SURMOUNT-1 trial enrolled 2,539 participants, which is large enough to detect effects occurring in roughly 1 in 200 people, but smaller effects can surface later in post-marketing surveillance. If you've started tirzepatide and developed a runny nose, it's worth being honest with yourself about whether anything else changed at the same time: the season, a new environment, a cold going round your household.

One misconception worth clearing up gently: some people assume that because GLP-1 medicines interact with the nervous system, every new physical symptom must be a drug effect. The reality is that correlation and causation are hard to untangle, and a cold that arrives in week three of a new medicine isn't automatically caused by it. That said, your experience matters, if you're noticing something unexpected, it's always worth noting it.

The physiological question: could tirzepatide plausibly cause this?

GLP-1 receptors are present in tissue beyond the gut, including parts of the nervous system that regulate secretions. Some research suggests GLP-1 agonists may influence autonomic pathways involved in mucus production, which is one reason nasal symptoms have occasionally appeared in discussion of this drug class. The evidence for this as a clinical effect of tirzepatide specifically is thin. Semaglutide (Wegovy) shares the GLP-1 pathway; tirzepatide adds GIP receptor activation on top. Neither is known to act directly on nasal tissue in a way that produces reliable, predictable rhinorrhoea.

What can produce a temporary runny nose is dehydration, which is a real risk for people who experience significant nausea or vomiting in the early weeks on a GLP-1 medicine. The body compensates for fluid shifts in various ways, and some people notice unusual symptoms that resolve once their GI tolerance improves and their hydration stabilises. If your runny nose arrived alongside nausea and has since settled, this context is useful. For a broader look at how tirzepatide works and what to expect, the tirzepatide overview on this site covers the mechanism in more depth.

When to take it further

Most runny noses are minor and self-resolving. For the majority of people on Mounjaro who notice nasal symptoms, watchful waiting for a week or two is reasonable, especially if the rest of your health picture is stable. If you're also considering the cost implications of ongoing treatment, you'll find an honest breakdown at our Mounjaro cost guide, which covers what private treatment typically includes.

There are circumstances where you should speak to a clinician sooner rather than later. A runny nose accompanied by severe nausea, signs of dehydration, or systemic symptoms is worth reviewing promptly. So is a persistent nosebleed rather than simple rhinorrhoea, that's a different symptom with its own considerations, and our page on whether Mounjaro can cause nosebleeds addresses it directly. If you're seeing blood rather than clear or coloured mucus, that page is a better starting point.

It's also worth knowing that suspected side effects from any prescription medicine can be reported directly to the MHRA via the Yellow Card scheme. You don't need a GP to do it, and it contributes to the post-marketing safety data that eventually sharpens prescribing guidance. If you've noticed something new on tirzepatide and it doesn't fit the standard side-effect list, a Yellow Card report is a straightforward way to flag it.

Deciding whether to mention it at your next review

Mounjaro is a prescription medicine, and every repeat supply at nume goes through a clinical re-review, there's no automatic renewal. That regular touchpoint exists precisely for moments like this. If your runny nose has been persistent for more than two or three weeks, is affecting your sleep or concentration, or you're simply not sure whether it belongs in the category of 'this medicine' or 'something else', mention it. A prescriber can look at your full picture, including your dose, how long you've been on treatment, and any other symptoms, in a way that a side-effect checklist cannot.

People who are active while on tirzepatide sometimes notice nasal symptoms during or after exercise, if that sounds familiar, the page on Mounjaro and running looks at how the medicine interacts with physical activity. And if you've noticed any other unusual sensory changes alongside nasal symptoms, our piece on a strange taste in the mouth on Mounjaro explores how the medicine can affect perception in subtler ways, and for something a little lighter, our collection of funny Mounjaro gifts is worth a browse if you know someone else on the same journey. Our clinical team reviews every consultation personally, so any concern you raise will land with a real prescriber, not a form.